We identified a novel combinatorial approach of paclitaxel and the small molecule inhibitor of PLK1, BI6727, to induce growth inhibition and apoptosis in ovarian cancer cell lines with CCNE1-amplification. Here, PLK1 is linked to ovarian cancer.